OR WAIT null SECS
January 09, 2017
Catalent announces a development agreement with JOT to evaluate softgel options for a resveratrol drug candidate.
November 04, 2016
The new facility will focus on formulation development, drug product analytical development, and quality control.
September 12, 2016
Saneca Pharma is making significant investment in its API capabilities to support client demand for smaller batch sizes and streamlined scale-up.
July 02, 2016
CPhI Pharma Awards seek nominations for excellence in development and manufacturing.
March 24, 2016
Collaboration will provide for unified development and manufacture of antibody drug conjugates.
February 19, 2016
PharmSource report addresses how the opportunity for antibody drug conjugates measures up to the bio/pharma industry’s expectations.
February 01, 2016
Sustainable harvesting combined with CMO expertise helped Centroflora CMS ensure supply continuity after it acquired Boehringer Ingelheim's non-captive API phytochemicals portfolio.
Mergers and acquisitions have changed the shape of the contract services market as big players seek to build full-service capabilities.
For successful partnerships, it’s important to take a long-term view, focus on simple designs, and address potential payer concerns up front.
January 28, 2016
Novasep is building a new synthesis laboratory and adding capacity for kilogram-scale batches of synthetic molecules that are needed for biological testing and preclinical trials, at its Pennsylvania, US facility.